Tirzepatide
medicationA weekly GIP and GLP-1 medication approved for weight management, sleep apnea and type 2 diabetes.
Guide
As listed on October 7, 2026, Zepbound costs $299 a month for the lowest strength through LillyDirect self-pay, $399 for the next, and $449 for higher strengths when refilled within 45 days. The list price is $499 to $1,086.37 per fill. With commercial coverage, the Zepbound Savings Card can bring a fill down to $25.

As listed on October 7, 2026, LillyDirect self-pay prices start at $299 a month for the lowest strength and $399 for the second. The four higher strengths are $449 a month when you refill within 45 days; a later refill costs $499 for the third strength and $699 for the top three. Lilly

Lilly lists the same prices for the vial, which is sold only through LillyDirect self-pay, and the KwikPen, which is also available for pickup at Walmart Pharmacy. A month means 28 days: four vials or one KwikPen. Lilly
Prices change. Check the date on any price you see, including these.
| Strength tier | Refilled within 45 days | Refilled later |
|---|---|---|
| Lowest strength (starting only, not for maintenance) | $299 | $299 |
| Second strength | $399 | $399 |
| Third strength | $449 | $499 |
| Fourth, fifth and sixth strengths | $449 | $699 |
Lilly gives the list price as $499 to $1,086.37 per fill, based on wholesale acquisition cost data accessed January 1, 2026. LillyDirect self-pay prices, listed above, sit below the top of that range. Lilly

Yes, for commercially insured patients. If your commercial plan covers the Zepbound single-use pen, the Savings Card lets eligible patients pay as little as $25 for a 1-, 2- or 3-month fill, with savings capped at $100 a month and $1,300 a calendar year, for up to 13 fills. The card expires December 31, 2026. Lilly

Through a temporary program, yes for some people. Under the Medicare GLP-1 Bridge, eligible Part D patients may get Zepbound for weight management for $50 a month, from July 1, 2026 through December 31, 2027, after prior authorization. Lilly (Jun 25, 2026)
TrumpRx.gov, the federal price listing site, showed the Zepbound vial at $299 a month on October 7, 2026, against an original price of $1,087, with orders placed through LillyDirect. That matches the lowest LillyDirect self-pay tier. TrumpRx.gov
It is not an equivalent. Compounded tirzepatide is not FDA-approved, and with the tirzepatide shortage resolved, FDA says pharmacies should not make copies of the approved drug; compounding is limited to a documented need for an identified patient. FDA
Price depends on your insurance, the form you are prescribed and how reliably you refill, so ask before the first fill.
Adds Tirzepatide to My Journal, with the questions to ask a clinician. It stays in this browser, and nothing on it is a commitment.
Licensed providers that list each one on DiscoverMedica, by name. The full list is on each compound’s page.
Prices as listed by the provider when we checked; they change.
Lilly’s Zepbound Savings Card works like a coupon for commercially insured patients: as little as $25 a fill when the plan covers it, as listed on October 7, 2026. It excludes people on Medicare, Medicaid and other government plans, and expires December 31, 2026.
As listed on October 7, 2026, LillyDirect self-pay starts at $299 a month for the lowest strength, rising to $449 for higher strengths when refills are on time. TrumpRx listed the vial at the same $299.
Under the Medicare GLP-1 Bridge, eligible Part D patients may pay $50 a month for the Zepbound KwikPen for weight management, from July 1, 2026 through December 31, 2027, after prior authorization.
Ask your plan. Self-pay purchases are made outside insurance, so you should confirm with your insurer whether they count toward a deductible or out-of-pocket limit.
Last reviewed October 7, 2026. Every source above was checked on or before that date. Educational information only, not medical advice; it does not replace a conversation with a licensed clinician. DiscoverMedica does not employ clinicians.
A weekly GIP and GLP-1 medication approved for weight management, sleep apnea and type 2 diabetes.